Search / 278 results found

from
to
  • Updated

THURSDAY, Jan. 27, 2022 (HealthDay News) -- In response to claims that a man was denied a heart transplant because he refused to get vaccinated against COVID-19, Brigham and Women's Hospital in Boston said Wednesday that its transplant policies mirror those used across the United States.

  • Updated

THURSDAY, Jan. 27, 2022 (HealthDay News) -- Finding the right medication for rheumatoid arthritis isn't easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms.

  • Updated

Studies ease concerns over COVID vaccine and menstrual cycles. They've gotten some media headlines recently, but potential menstrual changes associated with getting a COVID vaccine are typically minor and temporary, two new international studies confirm. Read more

  • Updated

WEDNESDAY, Jan. 26, 2022 (HealthDay News) -- Booster doses seem effective for the severe acute respiratory syndrome coronavirus 2 omicron variant, according to research published in the Jan. 21 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

  • Updated

WEDNESDAY, Jan. 26, 2022 (HealthDay News) -- Allopurinol, a frequently used gout medication, does not appear to drive up the risk for dying among gout patients who also struggle with chronic kidney disease, new research shows.

  • Updated

WEDNESDAY, Jan. 26, 2022 (HealthDay News) -- Preconception weight loss prior to infertility therapy does not improve live birth or healthy live birth rates in women who were obese or overweight, according to a study published online Jan. 18 in PLOS Medicine.

  • Updated

TUESDAY, Jan. 25, 2022 (HealthDay News) -- For patients with gout and chronic kidney disease (CKD), no associations with increased mortality were seen for allopurinol initiation, achieving target serum urate (SU) levels, or allopurinol dose escalation, according to a study published online Jan. 25 in the Annals of Internal Medicine.

MONDAY, Jan. 24, 2022 (HealthDay News) -- Schools should stock the opioid overdose antidote naloxone and train staff and students how to respond to an overdose, experts say after the apparent fentanyl overdose death of a seventh grader at a school in Hartford, Connecticut.